Cargando…
N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
Immunotherapy is a novel clinical approach that has shown clinical efficacy in multiple cancers. However, only a fraction of patients respond well to immunotherapy. Immuno-oncological studies have identified the type of tumors that are sensitive to immunotherapy, the so-called hot tumors, while unre...
Autores principales: | Zhan, Lei, Zhang, Junhui, Zhu, Suding, Liu, Xiaojing, Zhang, Jing, Wang, Wenyan, Fan, Yijun, Sun, Shiying, Wei, Bing, Cao, Yunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488118/ https://www.ncbi.nlm.nih.gov/pubmed/34616742 http://dx.doi.org/10.3389/fcell.2021.736298 |
Ejemplares similares
-
Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022) -
Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021) -
N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses
por: Feng, Qianyu, et al.
Publicado: (2021) -
Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022) -
N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
por: Luo, Jiahui, et al.
Publicado: (2021)